These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36226000)

  • 61. Perioral dermatitis: an uncommon condition?
    Hogan DJ; Epstein JD; Lane PR
    CMAJ; 1986 May; 134(9):1025-8. PubMed ID: 2938708
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency.
    Aubert-Wastiaux H; Moret L; Le Rhun A; Fontenoy AM; Nguyen JM; Leux C; Misery L; Young P; Chastaing M; Danou N; Lombrail P; Boralevi F; Lacour JP; Mazereeuw-Hautier J; Stalder JF; Barbarot S
    Br J Dermatol; 2011 Oct; 165(4):808-14. PubMed ID: 21671892
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Topical botulinum toxin.
    Collins A; Nasir A
    J Clin Aesthet Dermatol; 2010 Mar; 3(3):35-9. PubMed ID: 20725542
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
    Chu CY
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rosacea: An Update in Diagnosis, Classification and Management.
    Kang CN; Shah M; Tan J
    Skin Therapy Lett; 2021 Jul; 26(4):1-8. PubMed ID: 34347259
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
    Lekhanont K; Park CY; Smith JA; Combs JC; Preechawat P; Suwan-Apichon O; Rangsin R; Chuck RS
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):27-34. PubMed ID: 17341147
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Rosacea, acne and other diseases of the seborrheic spectrum].
    Böni R
    Praxis (Bern 1994); 2000 Mar; 89(14):566-70. PubMed ID: 10815463
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quality of health care of rosacea in Germany from the patient's perspective: results of the national health care study Rosareal 2009.
    Langenbruch AK; Beket E; Augustin M
    Dermatology; 2011; 223(2):124-30. PubMed ID: 21893958
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Off-Label Use of Botulinum Toxin in Dermatology-Current State of the Art.
    Lewandowski M; Świerczewska Z; Barańska-Rybak W
    Molecules; 2022 May; 27(10):. PubMed ID: 35630620
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative effectiveness of botulinum toxin versus non-surgical treatments for treating lateral epicondylitis: a systematic review and meta-analysis.
    Lin YC; Wu WT; Hsu YC; Han DS; Chang KV
    Clin Rehabil; 2018 Feb; 32(2):131-145. PubMed ID: 28349703
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rational management of papulopustular rosacea with concomitant facial seborrheic dermatitis: a case report.
    McFalda WL; Roebuck HL
    J Clin Aesthet Dermatol; 2011 Jan; 4(1):40-2. PubMed ID: 21278898
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Excellent response with platelet-rich plasma treatment in a case of steroid-induced rosacea-like dermatitis.
    Konuş A; Ertuğrul G; Aktaş H
    J Cosmet Dermatol; 2022 Jun; 21(6):2686-2687. PubMed ID: 34559462
    [No Abstract]   [Full Text] [Related]  

  • 73. Steroid rosacea in children.
    Franco HL; Weston WL
    Pediatrics; 1979 Jul; 64(1):36-8. PubMed ID: 156343
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The possible role of skin surface lipid in rosacea with epitheloid granulomas.
    Basta-Juzbasić A; Marinović T; Dobrić I; Bolanca-Bumber S; Sencar J
    Acta Med Croatica; 1992; 46(2):119-23. PubMed ID: 1384834
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Role of Topical Oxymetazoline for Management of Erythematotelangiectatic Rosacea.
    Hoover RM; Erramouspe J
    Ann Pharmacother; 2018 Mar; 52(3):263-267. PubMed ID: 29094614
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Topical metronidazole: a new therapy for rosacea.
    Schmadel LK; McEvoy GK
    Clin Pharm; 1990 Feb; 9(2):94-101. PubMed ID: 2137747
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy and safety of botulinum toxin a injection compared with topical nitroglycerin ointment for the treatment of chronic anal fissure: a prospective randomized study.
    Fruehauf H; Fried M; Wegmueller B; Bauerfeind P; Thumshirn M
    Am J Gastroenterol; 2006 Sep; 101(9):2107-12. PubMed ID: 16848808
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Unilateral transient mydriasis and ptosis after botulinum toxin injection for a cosmetic procedure.
    Akkaya S; Kökcen HK; Atakan T
    Clin Ophthalmol; 2015; 9():313-5. PubMed ID: 25709394
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Current status of external corticosteroid therapy].
    Gloor M
    Fortschr Med; 1985 Feb; 103(5):82-6. PubMed ID: 3156081
    [No Abstract]   [Full Text] [Related]  

  • 80. Botulin Toxin Use in Rosacea and Facial Flushing Treatment.
    Scala J; Vojvodic A; Vojvodic P; Vlaskovic-Jovicevic T; Peric-Hajzler Z; Matovic D; Dimitrijevic S; Vojvodic J; Sijan G; Stepic N; Wollina U; Tirant M; Thuong NV; Fioranelli M; Lotti T
    Open Access Maced J Med Sci; 2019 Sep; 7(18):2985-2987. PubMed ID: 31850105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.